BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Apnimed Announces Pricing of Upsized Initial Public Offering

  July 31, 2026

   · 

  4 min read
• Press Releases

  New Number of Shares and Votes in IRLAB Therapeutics AB

  July 31, 2026

   · 

  1 min read
• Press Releases

  CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial

  July 31, 2026

   · 

  3 min read
• Press Releases

  Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy

  July 31, 2026

   · 

  12 min read
• Press Releases

  Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate

  July 31, 2026

   · 

  4 min read
• Press Releases

  Cantargia Announces Changes in Number of Shares and Votes

  July 31, 2026

   · 

  1 min read
• Press Releases

  IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand

  July 31, 2026

   · 

  5 min read
• Press Releases

  Daiichi Sankyo Reports First Quarter Fiscal Year 2026 Financial Results

  July 31, 2026

   · 

  8 min read
• Press Releases

  Orano Med Provides Half-Year Progress Report and Business Outlook

  July 31, 2026

   · 

  7 min read
• Press Releases

  Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy

  July 31, 2026

   · 

  7 min read